| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Bihua Chen | Director, 10%+ Owner | $191,610,255 | 11 Aug 2025 | ||
| BridgeBio Pharma LLC | 10%+ Owner | $156,363,757 | 10 Oct 2025 | ||
| Mark C. McKenna | Former Director | $321,519 | 11 Aug 2025 | ||
| Albert A. Holman III | Former Director | $321,519 | 11 Aug 2025 | ||
| John P. Schmid | Former Director | $321,519 | 11 Aug 2025 | ||
| MICHELLE DOIG | Director | 11 Aug 2025 | |||
| Yong Ben | Chief Med & Dev Officer | 26 Aug 2025 | |||
| NEIL KUMAR | Director | 11 Aug 2025 | |||
| Jake Bauer | Director | 26 Aug 2025 | |||
| FRANK MCCORMICK | Director | 26 Aug 2025 | |||
| Praveen P. Tipirneni | Director | 26 Aug 2025 | |||
| Pedro Beltran | Chief Scientific Officer | 26 Aug 2025 | |||
| Uneek Mehra | Chief Financial Officer | 26 Aug 2025 | |||
| Eli M. Wallace | Chief Executive Officer, Director | 01 Jan 2026 | |||
| Raymond J. Kelleher | Director | 11 Aug 2025 | |||
| Caleb Tripp | Chief Financial Officer | 11 Aug 2025 | |||
| Nebojsa Obradovic | Chief Legal Officer | 11 Aug 2025 | |||
| Helix Holdings II LLC | Director, 10%+ Owner | 08 Feb 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|